Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Ombrabulin> ?p ?o }
Showing triples 1 to 54 of
54
with 100 triples per page.
- Ombrabulin abstract "Ombrabulin was an experimental drug candidate discovered by Ajinomoto and further developed by Sanofi-Aventis. Ombrabulin is a combretastatin A-4 derivative that exerts its antitumor effect by disrupting the formation of blood vessels needed for tumor growth. It was granted orphan drug status by the European Medicines Agency in April 2011. In January 2013, Sanofi said it discontinued development of ombrabulin after disappointing results from phase III clinical trials.".
- Ombrabulin iupacName "(2S)-2-Amino-3-hydroxy-N-[2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide".
- Ombrabulin thumbnail Ombrabulin.svg?width=300.
- Ombrabulin wikiPageID "32767728".
- Ombrabulin wikiPageLength "3802".
- Ombrabulin wikiPageOutDegree "10".
- Ombrabulin wikiPageRevisionID "670403677".
- Ombrabulin wikiPageWikiLink Ajinomoto.
- Ombrabulin wikiPageWikiLink Category:Amino_acid_derivatives.
- Ombrabulin wikiPageWikiLink Category:Experimental_cancer_drugs.
- Ombrabulin wikiPageWikiLink Combretastatin_A-4.
- Ombrabulin wikiPageWikiLink Derivative_(chemistry).
- Ombrabulin wikiPageWikiLink European_Medicines_Agency.
- Ombrabulin wikiPageWikiLink Hydrochloride.
- Ombrabulin wikiPageWikiLink Orphan_drug.
- Ombrabulin wikiPageWikiLink Sanofi.
- Ombrabulin wikiPageWikiLink Sanofi-Aventis.
- Ombrabulin wikiPageWikiLinkText "Ombrabulin".
- Ombrabulin wikiPageWikiLinkText "ombrabulin".
- Ombrabulin hasPhotoCollection Ombrabulin.
- Ombrabulin imagefile "Ombrabulin.svg".
- Ombrabulin imagesize "200".
- Ombrabulin iupacname "-2".
- Ombrabulin othernames "AVE-8062; AVE-8062A; AC7700; CS-39-L-Ser.HCl".
- Ombrabulin verifiedfields "changed".
- Ombrabulin verifiedrevid "445300917".
- Ombrabulin watchedfields "changed".
- Ombrabulin wikiPageUsesTemplate Template:Chembox.
- Ombrabulin wikiPageUsesTemplate Template:Reflist.
- Ombrabulin subject Category:Amino_acid_derivatives.
- Ombrabulin subject Category:Experimental_cancer_drugs.
- Ombrabulin hypernym Candidate.
- Ombrabulin type Article.
- Ombrabulin type ChemicalCompound.
- Ombrabulin type ChemicalSubstance.
- Ombrabulin type Drug.
- Ombrabulin type Person.
- Ombrabulin type Article.
- Ombrabulin type Chemical.
- Ombrabulin type Drug.
- Ombrabulin type ChemicalObject.
- Ombrabulin type Thing.
- Ombrabulin type Q11173.
- Ombrabulin comment "Ombrabulin was an experimental drug candidate discovered by Ajinomoto and further developed by Sanofi-Aventis. Ombrabulin is a combretastatin A-4 derivative that exerts its antitumor effect by disrupting the formation of blood vessels needed for tumor growth. It was granted orphan drug status by the European Medicines Agency in April 2011. In January 2013, Sanofi said it discontinued development of ombrabulin after disappointing results from phase III clinical trials.".
- Ombrabulin label "Ombrabulin".
- Ombrabulin sameAs امبرابولین.
- Ombrabulin sameAs m.0h3q5b0.
- Ombrabulin sameAs Ombrabulin.
- Ombrabulin sameAs Ombrabulin.
- Ombrabulin sameAs Q7089934.
- Ombrabulin sameAs Q7089934.
- Ombrabulin wasDerivedFrom Ombrabulin?oldid=670403677.
- Ombrabulin depiction Ombrabulin.svg.
- Ombrabulin isPrimaryTopicOf Ombrabulin.